iShares U.S. Medical Devices ETF(IHI)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 22 days
PROFIT SINCE LAST BUY
+0.93% ▲
LAST CLOSE
$55.38
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for IHI

11/20/2026: IHI (1-star) has a low Upturn Star Rating. Not recommended to BUY.

The iShares U.S. Medical Devices ETF (IHI) provides targeted exposure to domestic companies that manufacture and distribute medical equipment and devices by tracking the Dow Jones U.S. Select Medical Equipment Index. Its primary strengths lie in its high liquidity, dominant market share in the niche, and strong institutional backing from BlackRock. It serves as an effective satellite allocation for capturing secular healthcare innovation driven by aging populations. Key risks include heavy portfolio concentration in top holdings and valuation sensitivity to interest rate shifts. It is best suited for long-term growth-oriented investors willing to monitor sector-specific regulatory and policy developments.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitIt targets innovative medical technology companies capitalizing on structural secular growth trends.
Momentum investorStrong fit while signal remains positiveIt tends to exhibit strong relative performance trends during periods favoring healthcare innovation.
Value investorWeak fitMedical device equities often trade at premium valuation multiples due to high research and development demands.
Dividend/Income investorWeak fitThe portfolio emphasizes capital appreciation and R&D reinvestment rather than high dividend yields.
Low-risk investorMediumConcentration in a single industry sector exposes the fund to distinct regulatory and clinical trial risks.

Investor Profile

Ideal Investor Profile

Investors seeking targeted, long-term exposure to the structural growth trends of the U.S. medical device and technology industry.

Suitability

Best suited for long-term strategic investors looking to tilt their portfolios toward specialized healthcare innovation rather than active short-term traders.

Risk Profile

Risk factorLevelWhy it matters
VolatilityMedium / highSector concentration exposes the fund to sharper price swings than broad market indexes.
Market riskMedium / highMacroeconomic shifts and broader equity drawdowns heavily influence overall sector sentiment.
ConcentrationHighThe portfolio is heavily concentrated in a select group of top medical device holdings.
Tracking/expenseLowPassively managed sampling closely follows the target index with modest operational costs.
LiquidityLowHigh daily trading volumes ensure tight spreads and efficient secondary market execution.
Business/sector qualityHighUnderlying firms generally feature robust balance sheets, sticky customer relationships, and high barriers to entry.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

Exhibits moderate to high historical volatility driven by industry-specific regulatory headlines and growth stock sensitivity.

Market Risk

Subject to sector-wide pullbacks and vulnerability to shifts in macroeconomic risk appetite and interest rates.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
Single stockAbbott Laboratories (ABT)18.5Provides core exposure to a leading global medical device and healthcare giant.
Single stockIntuitive Surgical, Inc. (ISRG)15.2Captures high-growth exposure to advanced robotic-assisted surgical systems.
Single stockThermo Fisher Scientific Inc. (TMO)10.4Offers diversified exposure to analytical instruments, life sciences solutions, and specialized equipment.
Single stockMedtronic plc (MDT)8.8Adds foundational exposure to established medical technology and device manufacturing.
SectorU.S. Health Care Equipment & Supplies Industry47.1Encompasses the remaining portfolio allocation of specialized medical device and diagnostics equities.

Price Behavior

Flat / Range-Bound
PRICE PATH

Flat / Range-Bound

The stock price has been trading within a narrow range with minimal directional movement.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type ETF
Historic Profit -5.73%
Avg. Invested days 38
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
ETF Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.